Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

计划入组 60 人 · 首次发布于 2025 年 2 月 10 日

Phase II Clinical Study of JS207 (PD-1/VEGF Bispecific Antibody) Combination Therapies in Patients With Driver Gene-Positive, Advanced Non-Small Cell Lung Cancer After Failure of TKI Therapy

计划入组 78 人 · 首次发布于 2025 年 3 月 11 日

BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis

计划入组 21 人 · 首次发布于 2025 年 9 月 3 日

Bispecific antibody(AskGene)

Bispecific antibody(kexing)

CDX bispecific antibody

Cambridge Antibody Technology

New Zealand

Latticon Antibody Therapeutics, Inc

United States

OS Therapies

United States

Community Cancer Centers Face Implementation Hurdles with Bispecific Antibody Therapies

Cost-Effectiveness Analysis Critical for Optimizing CAR-T and Bispecific Therapies in Blood Cancers

Lunsumio Shows Durable 3-Year Remission in Follicular Lymphoma, Setting New Benchmark for Bispecific Antibodies